Abstract
Because of the characteristics of high invasiveness, relapse, and poor prognosis, the management of malignant gliomas has always been a great challenge. Nod-like receptor (NLR) family pyrin domain containing 3 (NLRP3) is a crucial component of the NLRP3 inflammasome, a multiprotein complex that can trigger caspase 1/interleukin-1 (IL-1)-mediated inflammatory response once activated and participates in the pathogeny of diverse inflammatory diseases as well as cancers. We examined the function of NLRP3 in the development of glioma. Glioma cells were treated with NLRP3 interference or overexpression vectors, recombinant IL-1β, IL-1β antibody, and NF-κB inhibitor. Cell proliferation and invasion were assessed by CCK-8 and Transwell assays. Gene expression was detected by PCR, Western blot, and ELISA. NLRP3 and NF-κB p65 increased and were positively correlated in glioma tissues. NLRP3 knockdown suppressed glioma cell growth and invasion with the decrease of IL-1β and NF-κB p65. Conversely, forced expression of NLRP3 promoted cell growth. NLRP3 silencing suppressed ectogenous IL-1β-elevated cell proliferation and invasion, whereas IL-1β elimination impaired the proproliferation effect of NLRP3 hyperexpression. Furthermore, NF-κB blo...Continue Reading
References
Aug 23, 2002·Molecular Cell·Fabio MartinonJürg Tschopp
Sep 22, 2005·Nature Reviews. Immunology·Michael Karin, Florian R Greten
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·S Perwez Hussain, Curtis C Harris
Apr 30, 2010·Nature·Peter DuewellEicke Latz
Jul 21, 2011·Nature Immunology·Yinon Ben-Neriah, Michael Karin
Dec 21, 2012·Nature·Michael T HenekaDouglas T Golenbock
May 25, 2013·Nature Reviews. Immunology·Eicke LatzAndrea Stutz
Aug 21, 2013·Nature Reviews. Immunology·J Simon C Arthur, Steven C Ley
Jul 24, 2014·Cell Biology International·K Fathima HurmathDalavaikodihalli Nanjaiah Nandakumar
Jul 24, 2014·PloS One·Leonid TarassishinSunhee C Lee
May 10, 2015·Vascular Pharmacology·So Young EunHye Jung Kim
Aug 26, 2015·Oncotarget·Zhenyu OuChawnshang Chang
Jun 14, 2016·Nature Reviews. Immunology·Petr Broz, Vishva M Dixit
Jan 5, 2017·Current Topics in Medicinal Chemistry·Kemel A GhotmeGjumrakch Aliev
Jan 18, 2017·Clinical Science·Natasha IrreraDomenica Altavilla
Mar 30, 2017·International Journal of Molecular Medicine·Bo ZhangDi Wu
Apr 22, 2017·Oncotarget·Ju Young BaeKyungpyo Park
May 6, 2017·Neuro-oncology·Quinn T OstromJill S Barnholtz-Sloan
May 10, 2017·The Lancet Oncology·Michael WellerUNKNOWN European Association for Neuro-Oncology (EANO) Task Force on Gliomas
Jun 6, 2017·Nature Reviews. Immunology·Shao-Cong Sun
Jun 24, 2017·Journal of Experimental & Clinical Cancer Research : CR·Xiaodong FengFuxiang Chen
Jun 28, 2017·Drug Design, Development and Therapy·Hui GeZhongfu Ma
Sep 9, 2017·PloS One·Zhiqiang ZhengQingfeng Chen
Sep 14, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexander WreeAriel E Feldstein
Citations
Feb 20, 2020·Cancers·Max HübnerSimone Kreth
Dec 1, 2018·Oncology and Therapy·Adi LitmanovichIdan Cohen
Dec 20, 2019·Molecular Immunology·Ji CaoHaitian Ma
Jan 16, 2021·Scientific Reports·Isabele F MorettiSuely K N Marie
Apr 9, 2021·Frontiers in Oncology·Meng ChengErbao Bian
Jun 9, 2021·Cancer Cell International·Wang ZhangZhiguo Lin
Jun 3, 2021·Cancers·Sonia MissiroliCarlotta Giorgi
Jun 25, 2021·BMC Cancer·Jiajie LuZhaotao Wang
Jul 10, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Ya-Xin LvDan-Dan Zhang
Aug 29, 2021·European Journal of Pharmacology·Abdullah Al MamunJian Xiao